Back to Search
Start Over
[Accuracy assessment of the blood glucose meter «Satellite Express» for glycemic control in children with diabetes]
- Source :
- Problemy endokrinologii. 65(6)
- Publication Year :
- 2020
-
Abstract
- Monitoring glycemic control in diabetes includes daily measurements of glucose levels at home, along with periodic monitoring of glycemia indicators on the whole. The main purpose of monitoring glycemic control is to accurately and authentically assess the glycemic level reached by each patient in order to ensure the glycemic goals achievement. Glycemic control assessment at a certain point in time is best achieved by self-monitoring the level of glucose in the blood, in that allows you to assess the presence of hyperglycemia and hypoglycemia to optimize the treatment strategy.Accuracy assessment of a medical devicelaquo;Portable blood glucose concentration meter with electrochemical single-use strip PKG-03laquo;Satellite Expressraquo; for glycemic control of children with diabetes.In a group of children with diabetes (n=105, age from 1 month to 17 years), simultaneously was taken capillary blood from one drop to assess the accuracy of glycemia levels on thelaquo;Satellite Expressraquo; glucose meter and on the laboratory glucose and lactate analyzer SUPER GL.In a comparative analysis of 660 blood samples on the Clark error scale, was found that all deviations of glycemia values obtained with thelaquo;Satellite Expressraquo; glucose meter were in zones A (99.7%mdash; clinically correct values) and B (0.3%mdash; safe deviations). The limits of permissible systematic error of measurements that meet the requirements of the National Standard of Russian Federation GOST R ISO 15197-2015 in terms of clause 6.3 System Accuracy amounted to 96.8% of deviations of glucose meter indications from reference values, which matches to areas of clinically correct and safe deviations.Using thelaquo;Satellite Expressraquo; glucose meter in clinical practice makes it possible to control glycemia qualitatively and it is safe for children aged from 1 month to 17 years.
Details
- ISSN :
- 23081430
- Volume :
- 65
- Issue :
- 6
- Database :
- OpenAIRE
- Journal :
- Problemy endokrinologii
- Accession number :
- edsair.pmid..........377d96643ea0fc588eeb686bd95d39ff